高宏集團 COWN 深 滬
已收盤 03-01 16:00:00 美东时间
38.99
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 38.99
- 總市值 110.12万
- 52周最高 38.95
- 市盈率 靜 17.65
- 換手率 0.00%
- 52周最低 20.97
- 委 比 0.00%
- 總股本 2.82万
- 歷史最高 43.27
- 量 比 0
- 振 幅 0.00%
- 歷史最低 4.61
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Enbridge reaffirms 5% post-2026 growth outlook while advancing $40B backlog
Earnings Call Insights: Enbridge Inc. (ENB) Q1 2026 Management View CEO Gregory Ebel said Q1 was “a strong start to the year,” adding, “We reaffirmed our '26 guidance and medium-term outlook and conti...
05-09 05:24
TD Cowen Maintains Hold on Sweetgreen, Raises Price Target to $7
TD Cowen analyst Andrew M. Charles maintains Sweetgreen (NYSE:SG) with a Hold and raises the price target from $5 to $7.
05-09 03:33
What's Going On With AMD Stock Friday?
AMD trades higher premarket as tech sentiment firms. With index futures up, traders continue to reward this leading AI-linked large-cap.
05-08 20:30
Why Is Micron Technology Stock Surging On Friday?
Micron Technology (MU) hits record highs of $683.09. Jim Cramer and Gartner analysts highlight "memflation" and secular AI growth driving the semiconductor rally.
05-08 20:05
BUZZ-Street View: Burgers, beverages and battle for traffic for McDonald's
BUZZ-Street View: Burgers, beverages and battle for traffic for McDonald's ** McDonald's MCD.N CEO Chris Kempczinski said on Thursday higher gas prices linked to the Iran war were disproportionately hurting low‑income consumers, as the burger chain warned of a weak start to its second quarter ** Co
05-08 16:41
Expedia publishes transcript of Q1 2026 earnings call
Expedia publishes transcript of Q1 2026 earnings call Expedia Group Q1 2026 earnings call drew CEO Ariane Gorin, CFO Scott Schenkel, VP investor relations Rob Bevegni; analysts included Morgan Stanley, Goldman Sachs, Bank of America, Oppenheimer, Wells Fargo, TD Cowen, Cantor Fitzgerald, Rothschild
05-08 16:15
Becton Dickinson Hikes Profit Outlook, Names CFO
Becton Dickinson (NYSE: BDX) tops Q2 estimates with $4.71B revenue and raises 2026 earnings outlook. New CFO Vitor Roque appointed.
05-08 02:29
Dutch Bros' first M&A deal starts to pay off
Dutch Bros (BROS) saw a benefit in Q1 from its first notable M&A deal. During Q1, the chain reopened 7 converted Clutch Coffee Bar shops and said the early response has been incredible. "Lines are for...
05-07 19:55
UroGen Pharma to Present at Upcoming Investor Conferences
UroGen Pharma Ltd. will participate in three investor conferences in May 2026: the Bank of America Health Care Conference on May 13th in Las Vegas, the HC Wainwright 4th Annual BioConnect Investor Conference on May 19th in New York, and the TD Cowen 7th Annual Oncology Innovation Summit on May 26th virtually. Webcasts will be available on UroGen’s Investor Relations website, with replays accessible for approximately 90 days.
05-07 12:00
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update
Korro Bio reported Q1 2026 progress, highlighting KRRO-121's potential as a first-in-class treatment for hyperammonemia in urea cycle disorders and hepatic encephalopathy, with regulatory filing expected in H2 2026. The company advanced its GalNAc-conjugated oligonucleotide for alpha-1 antitrypsin deficiency, achieving >90% in vivo RNA editing. Korro executed an $85M private placement to extend cash runway into H2 2028 and support multiple RNA ed...
05-07 11:00
